Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome

被引:154
|
作者
Agematsu, K
Nagumo, H
Shinozaki, K
Hokibara, S
Yasui, K
Terada, K
Kawamura, N
Toba, T
Nonoyama, S
Ochs, HD
Komiyama, A
机构
[1] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 390, Japan
[2] Kawasaki Med Sch, Dept Pediat, Kawasaki, Kanagawa, Japan
[3] Osaka Rosai Hosp, Dept Pediat, Osaka, Japan
[4] Chiba Childrens Hosp, Tiba, Japan
[5] Tokyo Med & Dent Univ, Dept Pediat, Tokyo 113, Japan
[6] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1998年 / 102卷 / 04期
关键词
hyper-IgM syndrome; memory B cells; CD40; CD27; CD70;
D O I
10.1172/JCI3409
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study analyzed peripheral blood B cell populations separated by IgD and CD27 expression in six males with X-linked hyper-IgM syndrome (XHIM). Costimulation of mononuclear cells from most of the patients induced no to low levels of class switching from IgM to IgG and IgA with Staphylococcus aureus Cowan strain (SAC) plus IL-2 or anti-CD40 mAb (anti-CD40) plus IL-10. Measurable levels of IgE were secreted in some of the patients after stimulation with anti-CD40 plus IL-4. Costimulation with SAC plus IL-2 plus anti-CD40 plus IL-10 yielded secretion of significant levels of IgG in addition to IgM, but not IgA. The most striking finding was that peripheral blood B cells from all of the six patients were composed of only IgD(+) CD27(-) and IgD(+) CD27(+) B cells; IgD(-) CD27(+) memory B cells were greatly decreased. IgD(+) CD27(+) B cells from an XHIM patient produced IgM predominantly. Our data indicate that the low response of IgG production in XHIM patients is due to reduced numbers of IgD(-) CD27(+) memory B cells. However, the IgG production can be induced by stimulation of immunoglobulin receptors and CD40 in cooperation with such cytokines as IL-2 and IL-10 in vitro.
引用
收藏
页码:853 / 860
页数:8
相关论文
共 50 条
  • [1] Clinical spectrum of X-linked hyper-IgM syndrome
    Levy, J
    EspanolBoren, T
    Thomas, C
    Fischer, A
    Tovo, P
    Bordigoni, P
    Resnick, I
    Fasth, A
    Baer, M
    Gomez, L
    Sanders, EAM
    Tabone, MD
    Plantaz, D
    Etzioni, A
    Monafo, V
    Abinun, M
    Hammarstrom, L
    Abrahamsen, T
    Jones, A
    Finn, A
    Klemola, T
    DeVries, E
    Sanal, O
    Peitsch, MC
    Notarangelo, LD
    JOURNAL OF PEDIATRICS, 1997, 131 (01): : 47 - 54
  • [2] A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency
    Ostenstad, B
    Giliani, S
    Mellbye, OJ
    Nilsen, BR
    Abrahamsen, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (02): : 230 - 234
  • [3] NEUROENDOCRINE CARCINOMA ASSOCIATED WITH X-LINKED HYPER-IGM SYNDROME
    Erdos, Melinda
    Garami, Miklos
    Rakoczi, Eva
    Zalatnai, Attila
    Steinbach, Daniel
    Baumann, Ulrich
    Kropshofer, Gabrielle
    Toth, Beata
    Marodi, Laszlo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 716 - 716
  • [4] Retrospective analysis of stem cell transplantations for X-linked hyper-IgM syndrome
    Imai, K.
    Tomizawa, D.
    Mitsui, K.
    Kajiwara, M.
    Nagasawa, M.
    Kogawa, K.
    Morio, T.
    Nonoyama, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S144 - S144
  • [5] PRENATAL-DIAGNOSIS OF X-LINKED HYPER-IGM SYNDROME
    DISANTO, JP
    MARKIEWICZ, S
    GAUCHAT, JF
    BONNEFOY, JY
    FISCHER, A
    DESAINTBASILE, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14): : 969 - 973
  • [6] Gene therapy for X-linked hyper-IgM syndrome.
    Zoltick, PW
    Genin, A
    Flake, AW
    Cron, RQ
    CLINICAL IMMUNOLOGY, 2005, 116 (03) : 304 - 304
  • [7] CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME
    CALLARD, RE
    ARMITAGE, RJ
    FANSLOW, WC
    SPRIGGS, MK
    IMMUNOLOGY TODAY, 1993, 14 (11): : 559 - 564
  • [8] X-linked immunodeficiency with hyper-IgM (XHIM)
    Notarangelo, LD
    Hayward, AR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (03): : 399 - 405
  • [9] Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome
    Tsuge, I
    Matsuoka, H
    Nakagawa, A
    Kamachi, Y
    Aso, K
    Negoro, T
    Ito, M
    Torii, S
    Watanabe, K
    EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (09) : 735 - 737
  • [10] Targeted Gene Therapy in the Treatment of X-Linked Hyper-IGM Syndrome
    Kuo, C. Y.
    Hoban, M. D.
    Joglekar, A. V.
    Kohn, D. B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S182 - S182